Pharmaceuticals face 100% tariffs in US
BBC • • nation
Key Points:
- The US will impose a 100% tariff on patented medicines entering the country, but pharmaceutical companies can avoid these taxes by striking deals with the administration, including commitments to manufacture in the US or pricing agreements.
- The tariffs aim to reduce national security risks by encouraging domestic production of key medicines, but they do not apply to generic medicines, which are the most commonly used in the US.
- Many major drug-makers have already negotiated agreements to avoid the tariffs, with smaller companies facing a higher risk of incurring the levies, potentially increasing their costs.
- The US will maintain lower tariffs on pharmaceutical imports from key partners like the UK, Europe, Japan, and South Korea, honoring existing trade agreements that include tariff exemptions.
- Experts caution that the overall impact of the tariffs is uncertain, as the effectiveness depends on the details of exemptions and deals, and increased domestic manufacturing may lead to higher costs despite potential price negotiations.
